Dissecting underlying mechanisms of aging
Aging is not a disease, but it is often accompanied by a complex array of chronic degenerative diseases. Sironax is committed to promoting healthier aging by targeting the underlying mechanisms of degeneration across various organs and tissues, including neuronal/axonal degeneration, muscle degeneration, epithelial cell death, neuroinflammation, and oxidative stress.
Explore our pipeline
A robust pipeline of first-in-class and best-in-class assets, including multiple clinical-stage small molecule programs and large molecule therapeutics enabled by our proprietary Brain Delivery Module (BDM) platform.
Company News
Jun. 30, 2025
Sironax Accelerates Global Expansion
May. 08, 2025
Sironax Story | Build the Bridge From Bench to Bedside for Degenerative Diseases